BTIG Reiterates Buy Rating on Vericel Corporation (VCEL)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to BTIG Reiterates Buy Rating on Vericel Corporation (VCEL)

Vericel Announces FDA Approval and Commercial Availability of MACI Arthro

August 26, 2024 7:45 AM EDT

First Restorative Biologic Cartilage Repair Product Approved for Arthroscopic Administration

Targets the Largest Segment of MACIs $3 Billion Addressable Market

CAMBRIDGE, Mass., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ: VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental Biologics License Application (sBLA) expanding the MACI® (autologous cultured chondrocytes on porcine collagen membrane) label to include arthroscopic delivery of MACI to repair... More